Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17-Reference-Cited by-同舟云学术

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17

Published:2008-05 Issue:5 Volume:19 Page:877-882
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ingle J.N.,Tu D.,Pater J.L.,Muss H.B.,Martino S.,Robert N.J.,Piccart M.J.,Castiglione M.,Shepherd L.E.,Pritchard K.I.,Livingston R.B.,Davidson N.E.,Norton L.,Perez E.A.,Abrams J.S.,Cameron D.A.,Palmer M.J.,Goss P.E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/5/877/399765/mdm566.pdf

Reference11 articles.

1. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer;Goss;N Engl J Med,2003

2. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17;Goss;J Natl Cancer Inst,2005

3. Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer;Moy;Ann Oncol,2006

4. Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial;Ingle;Breast Cancer Res Treat,2006

5. National Cancer Institute of Canada Clinical Trials Group MA.17: efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor;Goss;J Clin Oncol,2007

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07

2. 10 years or less of extended adjuvant endocrine therapy for postmenopausal breast cancer patients: A systematic review and network meta-analysis;European Journal of Cancer;2023-11

3. Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: A meta-analysis with trial sequential analysis of randomized controlled trials;Frontiers in Oncology;2022-10-27

4. Neoplasms of the Breast;Holland‐Frei Cancer Medicine;2022-10-21

5. Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality;Cancer Treatment Reviews;2022-04